Nnennaya A Ajayi1, Kingsley N Ukwaja1, Ngozi A Ifebunandu1, Richard Nnabu2, Francis I Onwe3, Danny A Asogun4. 1. Department of Internal Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria. 2. Department of Community Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria. 3. Department of Community Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria ; Epidemiology Unit, Ministry of Health, Ebonyi State, Nigeria. 4. Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Edo State, Nigeria.
Abstract
BACKGROUND: Lassa fever is a rodent-borne zoonosis that clinically manifests as an acute hemorrhagic fever. It is treated using ribavarin. Surviving Lassa fever without receiving the antiviral drug ribavarin is rare. Only few cases have been documented to date. CASE PRESENTATION: We report a case of a 59-year old female with fever who was initially thought to have acute pyelonephritis and sepsis syndrome with background malaria. Further changes in her clinical state and laboratory tests led to a suspicion of Lassa fever. However at the time her laboratory confirmatory test for Lassa fever returned, her clinical state had improved and she made full recovery without receiving ribavarin. Her close contacts showed no evidence of Lassa virus infection. CONCLUSION: This report adds to the literature on the natural history of Lassa fever; and that individuals may survive Lassa fever with conservative management of symptoms of the disease and its complications.
BACKGROUND: Lassa fever is a rodent-borne zoonosis that clinically manifests as an acute hemorrhagic fever. It is treated using ribavarin. Surviving Lassa fever without receiving the antiviral drug ribavarin is rare. Only few cases have been documented to date. CASE PRESENTATION: We report a case of a 59-year old female with fever who was initially thought to have acute pyelonephritis and sepsis syndrome with background malaria. Further changes in her clinical state and laboratory tests led to a suspicion of Lassa fever. However at the time her laboratory confirmatory test for Lassa fever returned, her clinical state had improved and she made full recovery without receiving ribavarin. Her close contacts showed no evidence of Lassa virus infection. CONCLUSION: This report adds to the literature on the natural history of Lassa fever; and that individuals may survive Lassa fever with conservative management of symptoms of the disease and its complications.
Authors: Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther Journal: J Clin Microbiol Date: 2010-03-29 Impact factor: 5.948
Authors: J B McCormick; I J King; P A Webb; C L Scribner; R B Craven; K M Johnson; L H Elliott; R Belmont-Williams Journal: N Engl J Med Date: 1986-01-02 Impact factor: 91.245
Authors: Walter H Haas; Thomas Breuer; Günter Pfaff; Herbert Schmitz; Päivi Köhler; Marcel Asper; Petra Emmerich; Christian Drosten; Uta Gölnitz; Klaus Fleischer; Stephan Günther Journal: Clin Infect Dis Date: 2003-05-09 Impact factor: 9.079
Authors: Danny A Asogun; Donatus I Adomeh; Jacqueline Ehimuan; Ikponmwonsa Odia; Meike Hass; Martin Gabriel; Stephan Olschläger; Beate Becker-Ziaja; Onikepe Folarin; Eric Phelan; Philomena E Ehiane; Veritas E Ifeh; Eghosasere A Uyigue; Yemisi T Oladapo; Ekene B Muoebonam; Osagie Osunde; Andrew Dongo; Peter O Okokhere; Sylvanus A Okogbenin; Mojeed Momoh; Sylvester O Alikah; Odigie C Akhuemokhan; Peter Imomeh; Maxy A C Odike; Stephen Gire; Kristian Andersen; Pardis C Sabeti; Christian T Happi; George O Akpede; Stephan Günther Journal: PLoS Negl Trop Dis Date: 2012-09-27
Authors: H O Akhiwu; E S Yiltok; A O Ebonyi; S Gomerep; N Y Shehu; E P Amaechi; A E Onukak; P Iduh; A A Oyagbemi; G Omame; P M Ashir; D Z Egah; S Oguche Journal: J Virus Erad Date: 2018-10-01
Authors: Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby Journal: BMC Med Date: 2019-06-11 Impact factor: 8.775
Authors: Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro Journal: PLoS Negl Trop Dis Date: 2021-09-21